Skip to main content
Clinical Trials/NCT04371198
NCT04371198
Completed
Not Applicable

Feasibility of Establishing Patient-Derived Organoids for Rectal Cancer: A Biospecimen Collection Protocol

Duke University1 site in 1 country20 target enrollmentSeptember 18, 2020
ConditionsRectum Cancer

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Rectum Cancer
Sponsor
Duke University
Enrollment
20
Locations
1
Primary Endpoint
Number of Participants With Biopsies That Form Spherical Organoids
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The purpose of this study is to determine the feasibility of establishing patient-derived organoids from pre-treatment rectal adenocarcinoma biopsies.

Registry
clinicaltrials.gov
Start Date
September 18, 2020
End Date
August 17, 2022
Last Updated
2 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Number of Participants With Biopsies That Form Spherical Organoids

Time Frame: Baseline

Study Sites (1)

Loading locations...

Similar Trials